{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:09:30Z","timestamp":1790118570186,"version":"4.0.1"},"reference-count":94,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,3,25]],"date-time":"2018-03-25T00:00:00Z","timestamp":1521936000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,3,25]],"date-time":"2018-03-25T00:00:00Z","timestamp":1521936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1111\/bjd.16080","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T11:02:39Z","timestamp":1509447759000},"page":"1011-1019","source":"Crossref","is-referenced-by-count":58,"title":["The non-neuronal and nonmuscular effects of botulinum toxin: an opportunity for a deadly molecule to treat disease in the skin and beyond"],"prefix":"10.1093","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5769-8938","authenticated-orcid":false,"given":"S.A.","family":"Grando","sequence":"first","affiliation":[{"name":"Department of Dermatology; University of California, Irvine; Irvine CA U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.B.","family":"Zachary","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of California, Irvine; Irvine CA U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,25]]},"reference":[{"key":"10.1111\/bjd.16080-BIB0001|bjd16080-cit-0001","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3390\/toxins4111196","article-title":"Emerging opportunities for serotypes of botulinum neurotoxins","volume":"4","author":"Peng Chen","year":"2012","journal-title":"Toxins (Basel)"},{"key":"10.1111\/bjd.16080-BIB0002|bjd16080-cit-0002","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jaad.2016.11.012","article-title":"Injectable and topical neurotoxins in dermatology: indications, adverse events, and controversies","volume":"76","author":"Giordano","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16080-BIB0003|bjd16080-cit-0003","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1083\/jcb.200910119","article-title":"Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin","volume":"189","author":"Sugawara","year":"2010","journal-title":"J Cell Biol"},{"key":"10.1111\/bjd.16080-BIB0004|bjd16080-cit-0004","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1126\/science.1253823","article-title":"Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex","volume":"344","author":"Lee","year":"2014","journal-title":"Science"},{"key":"10.1111\/bjd.16080-BIB0005|bjd16080-cit-0005","doi-asserted-by":"crossref","first-page":"e1003369","DOI":"10.1371\/journal.ppat.1003369","article-title":"Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT\/A)","volume":"9","author":"Jacky","year":"2013","journal-title":"PLOS Pathog"},{"key":"10.1111\/bjd.16080-BIB0006|bjd16080-cit-0006","doi-asserted-by":"crossref","first-page":"e0143024","DOI":"10.1371\/journal.pone.0143024","article-title":"Structural and functional interactions between transient receptor potential vanilloid subfamily 1 and botulinum neurotoxin serotype A","volume":"11","author":"Li","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1111\/bjd.16080-BIB0007|bjd16080-cit-0007","doi-asserted-by":"crossref","first-page":"199","DOI":"10.15430\/JCP.2014.19.3.199","article-title":"Fibroblast and epidermal growth factors utilize different signaling pathways to induce anchorage-independent cell transformation in JB6 Cl41 mouse skin epidermal cells","volume":"19","author":"Lee","year":"2014","journal-title":"J Cancer Prev"},{"key":"10.1111\/bjd.16080-BIB0008|bjd16080-cit-0008","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000297575","article-title":"FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature","volume":"220","author":"Blomberg","year":"2010","journal-title":"Dermatology"},{"key":"10.1111\/bjd.16080-BIB0009|bjd16080-cit-0009","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11626-016-0008-2","article-title":"Functional characteristics of mesenchymal stem cells derived from the adipose tissue of a patient with achondroplasia","volume":"52","author":"Park","year":"2016","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"10.1111\/bjd.16080-BIB0010|bjd16080-cit-0010","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2500\/ajra.2012.26.3785","article-title":"A novel botulinum neurotoxin topical gel: treatment of allergic rhinitis in rats and comparative safety profile","volume":"26","author":"Zhu","year":"2012","journal-title":"Am J Rhinol Allergy"},{"key":"10.1111\/bjd.16080-BIB0011|bjd16080-cit-0011","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/nau.22508","article-title":"Effect of botulinum toxin A on urothelial-release of ATP and expression of SNARE targets within the urothelium","volume":"34","author":"Hanna-Mitchell","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"10.1111\/bjd.16080-BIB0012|bjd16080-cit-0012","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1462-5822.2008.01253.x","article-title":"Differential entry of botulinum neurotoxin A into neuronal and intestinal cells","volume":"11","author":"Couesnon","year":"2009","journal-title":"Cell Microbiol"},{"key":"10.1111\/bjd.16080-BIB0013|bjd16080-cit-0013","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0140-6736(89)90087-1","article-title":"Immune dysfunction in patients not responding to hepatitis B vaccination","volume":"1","author":"Kitas","year":"1989","journal-title":"Lancet"},{"key":"10.1111\/bjd.16080-BIB0014|bjd16080-cit-0014","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5301\/RU.2012.9254","article-title":"[Botulinum toxin type-A toxin activity on prostate cancer cell lines]","volume":"79","author":"Proietti","year":"2012","journal-title":"Urologia"},{"key":"10.1111\/bjd.16080-BIB0015|bjd16080-cit-0015","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/713803537","article-title":"Proteolysis of synaptobrevin, syntaxin, and SNAP-25 in alveolar epithelial type II cells","volume":"48","author":"Zimmerman","year":"1999","journal-title":"IUBMB Life"},{"key":"10.1111\/bjd.16080-BIB0016|bjd16080-cit-0016","first-page":"8411","article-title":"Botulinum neurotoxin type A inhibits synaptic vesicle 2 expression in breast cancer cell lines","volume":"8","author":"Bandala","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1111\/bjd.16080-BIB0017|bjd16080-cit-0017","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1006\/bbrc.1997.7515","article-title":"Intracellular location of SNAP-25 in human neutrophils","volume":"239","author":"Nabokina","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/bjd.16080-BIB0018|bjd16080-cit-0018","doi-asserted-by":"crossref","first-page":"e0120840","DOI":"10.1371\/journal.pone.0120840","article-title":"Botulinum neurotoxin type A induces TLR2-mediated inflammatory responses in macrophages","volume":"10","author":"Kim","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1111\/bjd.16080-BIB0019|bjd16080-cit-0019","doi-asserted-by":"crossref","first-page":"C775","DOI":"10.1152\/ajpcell.2001.280.4.C775","article-title":"Role of SNAP-23 in trafficking of H + -ATPase in cultured inner medullary collecting duct cells","volume":"280","author":"Banerjee","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1111\/bjd.16080-BIB0020|bjd16080-cit-0020","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.bbrc.2006.03.093","article-title":"Epithelial sodium channel is regulated by SNAP-23\/syntaxin 1A interplay","volume":"343","author":"Saxena","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/bjd.16080-BIB0021|bjd16080-cit-0021","doi-asserted-by":"crossref","first-page":"13300","DOI":"10.1074\/jbc.271.23.13300","article-title":"Identification of a novel syntaxin- and synaptobrevin\/VAMP-binding protein, SNAP-23, expressed in non-neuronal tissues","volume":"271","author":"Ravichandran","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1111\/bjd.16080-BIB0022|bjd16080-cit-0022","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1124\/jpet.110.175018","article-title":"Evidence that botulinum toxin receptors on epithelial cells and neuronal cells are not identical: implications for development of a non-neurotropic vaccine","volume":"336","author":"Elias","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/bjd.16080-BIB0023|bjd16080-cit-0023","doi-asserted-by":"crossref","first-page":"e111170","DOI":"10.1371\/journal.pone.0111170","article-title":"Functional dissection of the Clostridium botulinum type B hemagglutinin complex: identification of the carbohydrate and E-cadherin binding sites","volume":"9","author":"Sugawara","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1111\/bjd.16080-BIB0024|bjd16080-cit-0024","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1111\/febs.13346","article-title":"Clostridium botulinum type C hemagglutinin affects the morphology and viability of cultured mammalian cells via binding to the ganglioside GM3","volume":"282","author":"Sugawara","year":"2015","journal-title":"FEBS J"},{"key":"10.1111\/bjd.16080-BIB0025|bjd16080-cit-0025","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.bbrc.2011.01.102","article-title":"Microarray analysis of differentially regulated genes in human neuronal and epithelial cell lines upon exposure to type A botulinum neurotoxin","volume":"405","author":"Thirunavukkarasusx","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/bjd.16080-BIB0026|bjd16080-cit-0026","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00702-015-1478-1","article-title":"Botulinum toxin drugs: brief history and outlook","volume":"123","author":"Dressler","year":"2016","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1111\/bjd.16080-BIB0027|bjd16080-cit-0027","doi-asserted-by":"crossref","DOI":"10.5005\/jp\/books\/12759","volume-title":"Handbook of Botulinum Toxins for Aesthetic Indications: Theory and Practice","author":"Beer","year":"2016"},{"key":"10.1111\/bjd.16080-BIB0028|bjd16080-cit-0028","first-page":"35","article-title":"Topical botulinum toxin","volume":"3","author":"Collins","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1111\/bjd.16080-BIB0029|bjd16080-cit-0029","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cps.2016.03.003","article-title":"Overview of botulinum toxins for aesthetic uses","volume":"43","author":"Gart","year":"2016","journal-title":"Clin Plast Surg"},{"key":"10.1111\/bjd.16080-BIB0030|bjd16080-cit-0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0974-2077.41148","article-title":"Botulinum toxin: non-cosmetic indications and possible mechanisms of action","volume":"1","author":"Wollina","year":"2008","journal-title":"J Cutan Aesthet Surg"},{"key":"10.1111\/bjd.16080-BIB0031|bjd16080-cit-0031","doi-asserted-by":"crossref","first-page":"837","DOI":"10.4088\/JCP.13m08845","article-title":"Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study","volume":"75","author":"Magid","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"5 Suppl.","key":"10.1111\/bjd.16080-BIB0032|bjd16080-cit-0032","doi-asserted-by":"crossref","first-page":"111S","DOI":"10.1097\/PRS.0000000000001733","article-title":"Neurotoxins: expanding uses of neuromodulators in medicine-major depressive disorder","volume":"136","author":"Magid","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"10.1111\/bjd.16080-BIB0033|bjd16080-cit-0033","first-page":"93","article-title":"[Botulinum toxin for the treatment of major depressive disorder]","volume":"82","author":"Hawlik","year":"2014","journal-title":"Fortschr Neurol Psychiatr"},{"key":"10.1111\/bjd.16080-BIB0034|bjd16080-cit-0034","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/jamafacial.2015.0376","article-title":"Alterations in the elasticity, pliability, and viscoelastic properties of facial skin after injection of onabotulinum toxin A","volume":"17","author":"Bonaparte","year":"2015","journal-title":"JAMA Facial Plast Surg"},{"key":"10.1111\/bjd.16080-BIB0035|bjd16080-cit-0035","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/dsu.12097","article-title":"Safety and efficacy of intradermal injection of botulinum toxin for the treatment of oily skin","volume":"39","author":"Rose","year":"2013","journal-title":"Dermatol Surg"},{"key":"10.1111\/bjd.16080-BIB0036|bjd16080-cit-0036","first-page":"847","article-title":"Use of intradermal botulinum toxin to reduce sebum production and facial pore size","volume":"7","author":"Shah","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.16080-BIB0037|bjd16080-cit-0037","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/excr.1999.4489","article-title":"Terminal differentiation of normal human oral keratinocytes is associated with enhanced cellular TGF-\u03b2 and phospholipase C-\u03b3 1 levels and apoptotic cell death","volume":"249","author":"Min","year":"1999","journal-title":"Exp Cell Res"},{"key":"10.1111\/bjd.16080-BIB0038|bjd16080-cit-0038","volume-title":"Botulinum Toxin in the Treatment or Prevention of Acne","author":"Caire","year":"2003"},{"key":"10.1111\/bjd.16080-BIB0039|bjd16080-cit-0039","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jdermsci.2013.06.009","article-title":"Regulation of lipid production by acetylcholine signalling in human sebaceous glands","volume":"72","author":"Li","year":"2013","journal-title":"J Dermatol Sci"},{"key":"10.1111\/bjd.16080-BIB0040|bjd16080-cit-0040","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/asj\/sju150","article-title":"Sebum production alteration after botulinum toxin type A injections for the treatment of forehead rhytides: a prospective randomized double-blind dose-comparative clinical investigation","volume":"35","author":"Min","year":"2015","journal-title":"Aesthet Surg J"},{"issue":"Suppl. 4","key":"10.1111\/bjd.16080-BIB0041|bjd16080-cit-0041","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/S0151-9638(09)74540-5","article-title":"[Botulinum toxin in disabling dermatological diseases]","volume":"136","author":"Messikh","year":"2009","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/bjd.16080-BIB0042|bjd16080-cit-0042","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000452341","article-title":"Botulinum toxin off-label use in dermatology: a review","volume":"3","author":"Campanati","year":"2017","journal-title":"Skin Appendage Disord"},{"key":"10.1111\/bjd.16080-BIB0043|bjd16080-cit-0043","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/09546630902877907","article-title":"Botulinum toxin type-A (BT-A) for the treatment of multiple eccrine hydrocystomas","volume":"21","author":"Ebrahimi","year":"2010","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.16080-BIB0044|bjd16080-cit-0044","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archdermatol.2008.575","article-title":"Successful treatment of eccrine angiomatous hamartoma with botulinum toxin","volume":"145","author":"Barco","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.16080-BIB0045|bjd16080-cit-0045","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1468-3083.2008.02630.x","article-title":"Efficacy of botulinum toxin for a congenital eccrine naevus","volume":"22","author":"Honeyman","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.16080-BIB0046|bjd16080-cit-0046","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00105-005-0919-4","article-title":"[Botulinum toxin treatment of eccrine sweat gland nevus]","volume":"56","author":"Sonntag","year":"2005","journal-title":"Hautarzt"},{"key":"10.1111\/bjd.16080-BIB0047|bjd16080-cit-0047","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/PRS.0b013e3181a80576","article-title":"Botox therapy for ischemic digits","volume":"124","author":"Neumeister","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"10.1111\/bjd.16080-BIB0048|bjd16080-cit-0048","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1001\/jamadermatol.2015.1793","article-title":"Efficacy of intralesional botulinum toxin A for treatment of painful cutaneous leiomyomas: a randomized clinical trial","volume":"151","author":"Naik","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1111\/bjd.16080-BIB0049|bjd16080-cit-0049","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2340\/00015555-2178","article-title":"Botulinum toxin A: an effective treatment for linear immunoglobulin A bullous dermatosis located in the axillae","volume":"96","author":"Legendre","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.16080-BIB0050|bjd16080-cit-0050","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1067\/mjd.2002.120455","article-title":"Botulinum toxin type A injection in the treatment of lichen simplex: an open pilot study","volume":"46","author":"Heckmann","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16080-BIB0051|bjd16080-cit-0051","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1468-2982.2006.01098.x","article-title":"Cephalalgic alopecia areata: a syndrome of neuralgiform head pain and hair loss responsive to botulinum A toxin injection","volume":"26","author":"Cutrer","year":"2006","journal-title":"Cephalalgia"},{"key":"10.1111\/bjd.16080-BIB0052|bjd16080-cit-0052","doi-asserted-by":"crossref","first-page":"246e","DOI":"10.1097\/PRS.0b013e3181ef816d","article-title":"Treatment of male pattern baldness with botulinum toxin: a pilot study","volume":"126","author":"Freund","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"10.1111\/bjd.16080-BIB0053|bjd16080-cit-0053","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/WNF.0b013e3181672225","article-title":"Relief of intractable pruritus after administration of botulinum toxin A (botox): a case report","volume":"31","author":"Salardini","year":"2008","journal-title":"Clin Neuropharmacol"},{"key":"10.1111\/bjd.16080-BIB0054|bjd16080-cit-0054","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1365-2133.2009.09305.x","article-title":"Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin","volume":"161","author":"Gazerani","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16080-BIB0055|bjd16080-cit-0055","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.burns.2012.05.014","article-title":"The use of botulinum toxin in the management of burns itching: preliminary results","volume":"38","author":"Akhtar","year":"2012","journal-title":"Burns"},{"key":"10.1111\/bjd.16080-BIB0056|bjd16080-cit-0056","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5826\/dpc.0601a06","article-title":"Vasculitis with panniculitis following botulinum toxin A injection for cosmetic use","volume":"6","author":"Namazi","year":"2016","journal-title":"Dermatol Pract Concept"},{"key":"10.1111\/bjd.16080-BIB0057|bjd16080-cit-0057","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/MBC.0000000000000317","article-title":"A case of thrombosis of subcutaneous anterior chest veins (Mondor's disease) as an unusual complication of botulinum type A injection","volume":"26","author":"Pisani","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/bjd.16080-BIB0058|bjd16080-cit-0058","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00105-015-3651-8","article-title":"[Cutaneous granulomatous reactions at botulinum neurotoxin A injection sites: First manifestation of systemic sarcoidosis]","volume":"66","author":"Herbert","year":"2015","journal-title":"Hautarzt"},{"key":"10.1111\/bjd.16080-BIB0059|bjd16080-cit-0059","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1038\/jid.2012.60","article-title":"Botulinum neurotoxin A decreases infiltrating cutaneous lymphocytes and improves acanthosis in the KC-Tie2 mouse model","volume":"132","author":"Ward","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16080-BIB0060|bjd16080-cit-0060","doi-asserted-by":"crossref","first-page":"S312","DOI":"10.1097\/DSS.0000000000001170","article-title":"Protective effect of botulinum toxin type A against atopic dermatitis-like skin lesions in NC\/Nga mice","volume":"43","author":"Han","year":"2017","journal-title":"Dermatol Surg"},{"key":"10.1111\/bjd.16080-BIB0061|bjd16080-cit-0061","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/WNR.0000000000000779","article-title":"Long-term anti-itch effect of botulinum neurotoxin A is associated with downregulation of TRPV1 and TRPA1 in the dorsal root ganglia in mice","volume":"28","author":"Cao","year":"2017","journal-title":"NeuroReport"},{"key":"10.1111\/bjd.16080-BIB0062|bjd16080-cit-0062","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.burns.2012.07.031","article-title":"The effects of botulinum toxin A on mast cell activity: preliminary results","volume":"39","author":"Park","year":"2013","journal-title":"Burns"},{"key":"10.1111\/bjd.16080-BIB0063|bjd16080-cit-0063","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1524-475X.2009.00477.x","article-title":"The effect of botulinum toxin A on skin flap survival in rats","volume":"17","author":"Kim","year":"2009","journal-title":"Wound Repair Regen"},{"key":"10.1111\/bjd.16080-BIB0064|bjd16080-cit-0064","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1085\/jgp.76.4.479","article-title":"Transient adaptation and sensitization in the retina of Necturus","volume":"76","author":"Karwoski","year":"1980","journal-title":"J Gen Physiol"},{"key":"10.1111\/bjd.16080-BIB0065|bjd16080-cit-0065","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.bjps.2016.02.006","article-title":"Increasing the survival of transverse rectus abdominis musculocutaneous flaps with a botulinum toxin-A injection: a comparison of surgical and chemical flap delay methods","volume":"69","author":"Temiz","year":"2016","journal-title":"J Plast Reconstr Aesthetic Surg"},{"key":"10.1111\/bjd.16080-BIB0066|bjd16080-cit-0066","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/nau.22501","article-title":"Re: Hanna-Mitchell AT, Wolf-Johnston AS, Barrick SR, et al. Effect of botulinum toxin A on urothelial-release of ATP and expression of SNARE targets within the urothelium. Neurourol Urodyn 2015;34:79-84","volume":"34","author":"Lavelle","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"10.1111\/bjd.16080-BIB0067|bjd16080-cit-0067","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/229255031502300309","article-title":"Prevention of unfavourable effects of cigarette smoke on flap viability using botulinum toxin in random pattern flaps: an experimental study","volume":"23","author":"Karayel","year":"2015","journal-title":"Plast Surg (Oakv)"},{"key":"10.1111\/bjd.16080-BIB0068|bjd16080-cit-0068","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1590\/S0102-865020150090000009","article-title":"Botulinum toxin type A on cutaneous flap viability in diabetic and tobacco-exposed rats","volume":"30","author":"Camargo","year":"2015","journal-title":"Acta Cir Bras"},{"key":"10.1111\/bjd.16080-BIB0069|bjd16080-cit-0069","doi-asserted-by":"crossref","first-page":"491e","DOI":"10.1097\/PRS.0000000000000030","article-title":"Inflammatory response and survival of pedicled abdominal flaps in a rat model after perivascular application of botulinum toxin type A","volume":"133","author":"Arnold","year":"2014","journal-title":"Plast Reconstr Surg"},{"key":"10.1111\/bjd.16080-BIB0070|bjd16080-cit-0070","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/SAP.0000000000000435","article-title":"Presurgical botulinum toxin A treatment increases angiogenesis by hypoxia-inducible factor-1\u03b1\/vascular endothelial growth factor and subsequent superiorly based transverse rectus abdominis myocutaneous flap survival in a rat model","volume":"76","author":"Park","year":"2016","journal-title":"Ann Plastic Surg"},{"key":"10.1111\/bjd.16080-BIB0071|bjd16080-cit-0071","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.bjps.2007.12.034","article-title":"The effects of botulinum toxin A on the survival of a random cutaneous flap","volume":"62","author":"Kim","year":"2009","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1111\/bjd.16080-BIB0072|bjd16080-cit-0072","doi-asserted-by":"crossref","first-page":"9072","DOI":"10.1038\/srep09072","article-title":"Protective effect of botulinum toxin A after cutaneous ischemia-reperfusion injury","volume":"5","author":"Uchiyama","year":"2015","journal-title":"Sci Rep"},{"key":"10.1111\/bjd.16080-BIB0073|bjd16080-cit-0073","first-page":"9458","article-title":"Effect of botulinum neurotoxin type A (BoNTA) on the morphology and viability of 3T3 murine fibroblasts","volume":"8","author":"Bandala","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1111\/bjd.16080-BIB0074|bjd16080-cit-0074","first-page":"787","article-title":"[The intrauterine development of man]","volume":"44","author":"Roszkowski","year":"1973","journal-title":"Ginekol Pol"},{"key":"10.1111\/bjd.16080-BIB0075|bjd16080-cit-0075","doi-asserted-by":"crossref","first-page":"821e","DOI":"10.1097\/PRS.0000000000002625","article-title":"Effect of botulinum toxin type A on TGF-\u03b2\/Smad pathway signaling: implications for silicone-induced capsule formation","volume":"138","author":"Kim","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"10.1111\/bjd.16080-BIB0076|bjd16080-cit-0076","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/iwj.12228","article-title":"The effect of botulinum neurotoxin type A on capsule formation around silicone implants: the in vivo and in vitro study","volume":"13","author":"Lee","year":"2016","journal-title":"Int Wound J"},{"key":"10.1111\/bjd.16080-BIB0077|bjd16080-cit-0077","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1524-4725.2012.02504.x","article-title":"The potential effect of botulinum toxin type A on human dermal fibroblasts: an in vitro study","volume":"38","author":"Oh","year":"2012","journal-title":"Dermatol Surg"},{"key":"10.1111\/bjd.16080-BIB0078|bjd16080-cit-0078","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1097\/SCS.0000000000000941","article-title":"The effects of botulinum toxin A on the wound and skin graft contraction","volume":"25","author":"Kucukkaya","year":"2014","journal-title":"J Craniofac Surg"},{"key":"10.1111\/bjd.16080-BIB0079|bjd16080-cit-0079","first-page":"389","article-title":"Rat model of burn wound healing: effect of Botox","volume":"26","author":"Abdallah Hajj Hussein","year":"2012","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1111\/bjd.16080-BIB0080|bjd16080-cit-0080","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.3390\/molecules17022169","article-title":"Effects of botulinum toxin type A on collagen deposition in hypertrophic scars","volume":"17","author":"Xiao","year":"2012","journal-title":"Molecules"},{"key":"10.1111\/bjd.16080-BIB0081|bjd16080-cit-0081","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/SCS.0000000000002272","article-title":"Botulinum toxin A upregulates Rac1, Cdc42, and RhoA gene expression in a dose-dependent manner: in vivo and in vitro study","volume":"27","author":"Park","year":"2016","journal-title":"J Craniofac Surg"},{"key":"10.1111\/bjd.16080-BIB0082|bjd16080-cit-0082","doi-asserted-by":"crossref","first-page":"171e","DOI":"10.1097\/PRS.0000000000001438","article-title":"Effect of botulinum toxin type A on differentiation of fibroblasts derived from scar tissue","volume":"136","author":"Jeong","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"10.1111\/bjd.16080-BIB0083|bjd16080-cit-0083","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/1090820X13482938","article-title":"Effects of botulinum toxin type A on expression of genes in keloid fibroblasts","volume":"34","author":"Xiaoxue","year":"2014","journal-title":"Aesthet Surg J"},{"key":"10.1111\/bjd.16080-BIB0084|bjd16080-cit-0084","first-page":"118","article-title":"[Effects of botulinum toxin type A on the expression of alpha-SMA and myosin-II of fibroblasts in scars]","volume":"30","author":"Yan","year":"2014","journal-title":"Zhonghua Zheng Xing Wai Ke Za Zhi"},{"key":"10.1111\/bjd.16080-BIB0085|bjd16080-cit-0085","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1097\/SAP.0000000000000268","article-title":"Botulinum toxin type A inhibits \u03b1-smooth muscle actin and myosin II expression in fibroblasts derived from scar contracture","volume":"77","author":"Chen","year":"2016","journal-title":"Ann Plast Surg"},{"key":"10.1111\/bjd.16080-BIB0086|bjd16080-cit-0086","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s00266-011-9690-3","article-title":"Botulinum toxin type A inhibits connective tissue growth factor expression in fibroblasts derived from hypertrophic scar","volume":"35","author":"Xiao","year":"2011","journal-title":"Aesthetic Plast Surg"},{"key":"10.1111\/bjd.16080-BIB0087|bjd16080-cit-0087","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00266-009-9423-z","article-title":"Effect of botulinum toxin type A on transforming growth factor \u03b21 in fibroblasts derived from hypertrophic scar: a preliminary report","volume":"34","author":"Xiao","year":"2010","journal-title":"Aesthetic Plast Surg"},{"key":"10.1111\/bjd.16080-BIB0088|bjd16080-cit-0088","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.bjps.2008.05.003","article-title":"Botulinum toxin type A affects cell cycle distribution of fibroblasts derived from hypertrophic scar","volume":"61","author":"Zhibo","year":"2008","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1111\/bjd.16080-BIB0089|bjd16080-cit-0089","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.eururo.2008.05.007","article-title":"Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats","volume":"56","author":"Chuang","year":"2009","journal-title":"Eur Urol"},{"key":"10.1111\/bjd.16080-BIB0090|bjd16080-cit-0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12640-013-9447-7","article-title":"Anti-inflammatory effects of botulinum toxin type A in a complete Freund's adjuvant-induced arthritic knee joint of hind leg on rat model","volume":"26","author":"Yoo","year":"2014","journal-title":"Neurotox Res"},{"key":"10.1111\/bjd.16080-BIB0091|bjd16080-cit-0091","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/pros.20958","article-title":"Botulinum toxin type A inhibits the growth of LNCaP human prostate cancer cells in vitro and in vivo","volume":"69","author":"Karsenty","year":"2009","journal-title":"Prostate"},{"key":"10.1111\/bjd.16080-BIB0092|bjd16080-cit-0092","first-page":"379","article-title":"[Wegener's granulomatosis]","volume":"35","author":"Esca","year":"1984","journal-title":"Hautarzt"},{"key":"10.1111\/bjd.16080-BIB0093|bjd16080-cit-0093","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.urology.2009.01.047","article-title":"Effects of purified newly developed botulinum neurotoxin type A in rat prostate","volume":"74","author":"Nishiyama","year":"2009","journal-title":"Urology"},{"key":"10.1111\/bjd.16080-BIB0094|bjd16080-cit-0094","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2490-12-1","article-title":"Expression of apoptosis-regulating genes in the rat prostate following botulinum toxin type A injection","volume":"12","author":"Gorgal","year":"2012","journal-title":"BMC Urol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.16080","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.16080\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:34:25Z","timestamp":1676381665000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/178\/5\/1011\/6753061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,25]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.16080","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3,25]]}}}